Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors

J.M. Rosenholm, E. Peuhu, L.T. Bate-Eya, J.E. Eriksson, C. Sahlgren, M. Lindén

    Research output: Contribution to journalArticleAcademicpeer-review

    142 Citations (Scopus)

    Abstract

    Targeted delivery of the chemotherapeutic agent methotrexate (MTX) to cancer cells using poly(ethyleneimine)-functionalized mesoporous silica particles as drug-delivery vectors is reported. Due to its high affinity for folate receptors, the expression of which is elevated in cancer cells, MTX serves as both a targeting ligand and a cytotoxic agent. Enhanced cancer-cell apoptosis (programmed cell death) relative to free MTX is thus observed at particle concentrations where nonspecific MTX-induced apoptosis is not observed in the nontargeted healthy cell line, while corresponding amounts of free drug affect both cell lines equally. The particles remain compartmentalized in endo-/lysosomes during the time of observation (up to 72 h), while the drug is released from the particle only upon cell entry, thereby inducing selective apoptosis in the target cells. As MTX is mainly attached to the particle surface, an additional advantage is that the presented carrier design allows for adsorption (loading) of additional drugs into the pore network for therapies based on a combination of drugs. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA.
    Original languageEnglish
    Pages (from-to)1234-1241
    JournalSmall
    Volume6
    Issue number11
    DOIs
    Publication statusPublished - 2010

    Fingerprint

    Dive into the research topics of 'Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors'. Together they form a unique fingerprint.

    Cite this